In this study, PTHrP expression was detected by an antibody to the amino terminal region (1–34) in 68% of primary tumor specimens compared with 100% of bone metastases and the PTHrP receptor was present in 37% of tumors compared with 81% of bone metastasis samples. This evidence concerns the gene PTHLH and neoplasm.